The authors tested the device with 48 participants, 37 of whom had little or no prior laboratory experience. Compared with paper instructions, the device helped users pool mock clinical samples with ...
Morning Overview on MSN
A national lab study finds the bacteria behind most urinary infections are beating today’s antibiotics
Roughly one in three uropathogenic E. coli samples collected by a national laboratory turned out to be resistant to multiple ...
The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results